A New Trade Framework for Global Healthcare R&D
Current business models for drug development are inefficient and ineffective - drugs are not reaching all who need them. Hubbard and Love contend that it is time to explore some alternatives
Salvato in:
| Pubblicato in: | PLoS Biol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
PLOS
2004
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC340954/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/14966544/ https://ncbi.nlm.nih.govhttps://doi.org/10.1371/journal.pbio.0020052 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|